Publications

Search for a publication

List of publications

Sort by: Date | Author | Title

Yale, J. F., Bodholdt, U., Catarig, A. M., Catrina, S., Clark, A., Ekberg, N. R., Erhan, U., Holmes, P., Knudsen, S. T., Liutkus, J., Sathyapalan, T., Schultes, B. & Rudofsky, G. (2022). Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Pooled analysis of data from four SURE studies by baseline characteristic subgroups. BMJ Open Diabetes Research & Care, 10(2), Article e002619. https://doi.org/10.1136/bmjdrc-2021-002619
Yakar, S., Liu, J. L., Fernandez, A. M., Wu, Y., Schally, A. V., Frystyk, J., Chernausek, S. D., Mejia, W. & Le Roith, D. (2001). Liver-specific IGF-I gene deletion leads to muscle insulin insensitivity. Diabetes, 50(5), 1110-1118.
Yakar, S., Rosen, C. J., Beamer, W. G., Ackert-Bicknell, C. L., Wu, Y., Liu, J. L., Ooi, G. T., Setser, J., Frystyk, J., Boisclair, Y. R. & LeRoith, D. (2002). Circulating levels of IGF-1 directly regulate bone growth and density. J. Clin. Invest., 110(6), 771-781.
Yakar, S., Rosen, C. J., Bouxsein, M. L., Sun, H., Mejia, W., Kawashima, Y., Wu, Y., Emerton, K., Williams, V., Jepsen, K., Schaffler, M. B., Majeska, R. J., Gavrilova, O., Gutierrez, M., Hwang, D., Pennisi, P., Frystyk, J., Boisclair, Y., Pintar, J. ... LeRoith, D. (2009). Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism. The FASEB Journal, 23(3), 709-19. https://doi.org/10.1096/fj.08-118976
Xiang, X., Corsi, G. I., Anthon, C., Qu, K., Pan, X., Liang, X., Han, P., Dong, Z., Liu, L., Zhong, J., Ma, T., Wang, J., Zhang, X., Jiang, H., Xu, F., Liu, X., Xu, X., Wang, J., Yang, H. ... Luo, Y. (2021). Enhancing CRISPR-Cas9 gRNA efficiency prediction by data integration and deep learning. Nature Communications, 12(1), Article 3238. https://doi.org/10.1038/s41467-021-23576-0
Wong, C. K., McLean, B. A., Baggio, L. L., Koehler, J. A., Hammoud, R., Rittig, N., Yabut, J. M., Seeley, R. J., Brown, T. J. & Drucker, D. J. (2024). Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation. Cell Metabolism, 36(1), 130-143. https://doi.org/10.1016/j.cmet.2023.11.009